tirzepatide patent expiry date Semaglutide in India opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent When Does Semaglutide Patent Expire?

Despite an acknowledged twofold risk of acute pancreatitis in type 2 diabetes, inclusion of an acute pancreatitis risk label, and low risk in retrospective studies, large cardiovascular safety studies did not confirm significant signals

Delays in getting specific pens or strengths needed for fine-tuning therapy

TGs were 28% (AUC 08h ) and 57% (iAUC 08h ) lower with liraglutide vs

Semaglutide is a GLP-1 receptor agonist that mimics the action of a natural hormone, leading to reduced appetite, enhanced satiety, and improved blood sugar control

Drin for sharing such important outcomes!

WIDER IMPLICATIONS OF THE FINDINGS The results are compatible with the hypothesis that diabetes-related factors, rather than GLP-1 receptor agonist exposure itself, may contribute to the increased preterm birth risk